Loading...
Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat
Cisplatin, a chemotherapeutic agent of choice for the treatment of solid tumors, produces hearing loss in approximately half a million new cancer patients annually in the United States. The hearing loss is due, in part, to increased generation of reactive oxygen species (ROS) in the cochlea, leading...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Society for Neuroscience
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2865180/ https://ncbi.nlm.nih.gov/pubmed/19052196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1307-08.2008 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|